참고문헌
- Laurie SW, Kaban LB, Mulliken JB, Murray JE. Donor-site morbidity after harvesting rib and iliac bone. Plast Reconstr Surg 1984;73:933-8. https://doi.org/10.1097/00006534-198406000-00014
- Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-5. https://doi.org/10.1097/00005131-198909000-00002
- Dumas JE, Davis T, Holt GE, et al. Synthesis, characterization, and remodeling of weight-bearing allograft bone/polyurethane composites in the rabbit. Acta Biomater 2010;6: 2394-406. https://doi.org/10.1016/j.actbio.2010.01.030
- Hagen A, Gorenoi V, Schonermark MP. Bone graft substitutes for the treatment of traumatic fractures of the extremities. GMS Health Technol Assess 2012;8:Doc04. [Epub]
- Hing KA, Best SM, Tanner KE, Bonfield W, Revell PA. Quantification of bone ingrowth within bone-derived porous hydroxyapatite implants of varying density. J Mater Sci Mater Med 1999;10:663-70. https://doi.org/10.1023/A:1008900127475
- Liu DM. Fabrication and characterization of porous hydroxyapatite granules. Biomaterials 1996;17:1955-7. https://doi.org/10.1016/0142-9612(95)00301-0
- Frame JW. Hydroxyapatite as a biomaterial for alveolar ridge augmentation. Int J Oral Maxillofac Surg 1987;16:642-55. https://doi.org/10.1016/S0901-5027(87)80048-6
- Abd El-Fattah H, Helmy Y, El-Kholy B, Marie M. In vivo animal histomorphometric study for evaluating biocompatibility and osteointegration of nano-hydroxyapatite as biomaterials in tissue engineering. J Egypt Natl Canc Inst 2010;22:241-50.
- National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of 4-Hexylresorcinol (CAS No. 136-77-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies). Natl Toxicol Program Tech Rep Ser 1988;330:1-166.
- Iyidogan NF, Bayindirli A. Effect of L-cysteine, kojic acid and 4-hexylresorcinol combination on inhibition of enzymatic browning in Amasya apple juice. J Food Eng 2004;62:299-304. https://doi.org/10.1016/S0260-8774(03)00243-7
- Martinez-Alvarez O, Lopez-Caballero ME, Montero P, Gomez- Guillena MC. Spraying of 4-hexylresorcinol based formulations to prevent enzymatic browning in Norway lobsters (Nephropsnorvegicus) during chilled storage. Food Chem 2007;100: 147-55. https://doi.org/10.1016/j.foodchem.2005.09.031
-
Kim SG, Lee SW, Park YW, Jeong JH, Choi JY. 4-hexylresorcinol inhibits NF-
${\kappa}B$ phosphorylation and has a synergistic effect with cisplatin in KB cells. Oncol Rep 2011; 26:1527-32. - Kim SG, Jeong JH, Park YW, et al. 4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells. Oncol Rep 2011;25:1597-602.
- Misch CE, Dietsh F. Bone-grafting materials in implant dentistry. Implant Dent 1993;2:158-67. https://doi.org/10.1097/00008505-199309000-00003
- Peres JA, Lamano T. Strategies for stimulation of new bone formation: a critical review. Braz Dent J 2011;22:443-8. https://doi.org/10.1590/S0103-64402011000600001
- Kim SG, Hahn BD, Park DS, et al. Aerosol deposition of hydroxyapatite and 4-hexylresorcinol coatings on titanium alloys for dental implants. J Oral Maxillofac Surg 2011;69: e354-63. https://doi.org/10.1016/j.joms.2011.06.002